News

COVID-19 cases are rising in more than half of states. Is the US in a summer wave? What to know about COVID trends and ...
Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...
No improvement in clinical outcomes occurred among inpatients with COVID-19 who received nirtmatrelvir-ritonavir or molnupiravir in addition to usual care.
An office worker surnamed Lee recently experienced high fever, chills, and muscle pain. At first, Lee thought it was just a summer cold or air conditioning sickness and took cold medicine. But ...
COVID-19 is caused by the SARS-CoV-2 virus. ... Paxlovid is the leading COVID-19 treatment, but is currently only recommended for people who are considered at risk of severe disease.
The data from this prospective cohort study confirm and expand previous retrospective case series that have found factors, including hematologic cancers, chemotherapy receipt, and lung cancer, as ...
COVID-19 activity is yet again on the rise in Hawaii, according to the latest report from the Hawaii Department of Health.
Although we may not hear much about it these days, long COVID-19 is still out there. In the beginning, treatment seemed to be a hit-and-miss, but the approach has had a breakthrough.